AnthonyLangoneMD

PubMed

• Twelve-month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients.
  Binari, L., Thorne, P., Rega, S., Feurer, I., Shawar, S., Naik, R., Birdwell, K., Helderman, J., Langone, A., Sarrell, B., Schaefer, H., DuBray, B., Eid, K., Hickman, ...> ;Transplant Infectious Disease. 2024 Feb 1
• 12 citations
  Clinical Validation of an Immune Quiescence Gene Expression Signature in Kidney Transplantation.
  Enver Akalin, Matthew R Weir, Suphamai Bunnapradist, Daniel C Brennan, Rowena Delos Santos, Anthony Langone, Arjang Djamali, Hua Xu, Xia Jin, Sham Dholakia, Robert N W...> ;Kidney360. 2021 Dec 30
• 39 citations
  Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients.
  Bonnie Ann Sarrell, Karen C. Bloch, Alissar El Chediak, Kayla Kumm, Rachel C. Forbes, Anthony Langone, Lora D. Thomas, Kelly Schlendorf, Anil J. Trindade, Roman E. Per...> ;Transplant Infectious Disease. 2021 Nov 17
• 5 citations
  Kidney Transplantation From Hepatitis C Viremic Deceased Donors to Aviremic Recipients in a Real-world Setting.
  Beatrice P. Concepcion, Laura A Binari, Heidi M. Schaefer, Scott A. Rega, Irene D. Feurer, Saed H. Shawar, Ruchi Naik, Laura Hickman, Jasmine Walker, Meghan E. Kapp, K...> ;Transplantation Direct. 2021 Sep 7
• 3 citations
  Integrating pharmacists into a kidney transplant clinic: Developing and implementing a collaborative pharmacy practice agreement
  Keren E. Rodriguez, Rachel J. Chelewski, Megan E. Peter, Autumn D Zuckerman, Leena Choi, Josh DeClercq, Anthony Langone> ;Journal of the American Pharmacists Association. 2021 Jul 13
• 2 citations
  The effect of pulsatile pump perfusion on hepatitis C transmission in kidney transplantation: A prospective pilot study.
  Rachel C. Forbes, Beatrice P. Concepcion, Deana Clapper, Bernard J. DuBray, Saed H. Shawar, Heidi M. Schaefer, Anthony Langone, David Williamson Shaffer, Keith Johnson> ;Clinical Transplantation. 2020 Aug 1
• 7 citations
  How Should We Manage Renal Transplant Patients with Failed Allografts Who Return to Dialysis
  Guneet S Kochar, Anthony Langone> ;Blood Purification. 2020 Jan 7
• 11 citations
  Unexpected Race and Ethnicity Differences in the US National Veterans Affairs Kidney Transplant Program.
  Larissa Myaskovsky, Kellee Kendall, Xingyuan Li, Chung-Chou H. Chang, John R. Pleis, Emilee Croswell, C. Graham Ford, Galen E. Switzer, Anthony Langone, Anuja Mittal-H...> ;Transplantation. 2019 Dec 1
• 71 citations
  Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients.
  Stanley C. Jordan, Suphamai Bunnapradist, Jonathan S. Bromberg, Anthony Langone, D. Hiller, J. Yee, John J. Sninsky, Robert Woodward, Arthur J. Matas> ;Transplantation Direct. 2018 Aug 20
• Thin Glomerular Basement Membrane in a Kidney Transplant of an Alport's Syndrome Patient: A Case Report.
  S. Santos, S. Marques, T. Golper, Anthony Langone, Agnes B. Fogo> ;Transplantation Proceedings. 2017 Dec 1
• 58 citations
  Biological Variation of Donor-Derived Cell-Free DNA in Renal Transplant Recipients: Clinical Implications
  Jonathan S. Bromberg, Daniel C. Brennan, Emilio D. Poggio, Suphamai Bunnapradist, Anthony Langone, Puneet Sood, Arthur J. Matas, Roslyn B. Mannon, Shikha Mehta, Asif S...> ;The Journal of Applied Laboratory Medicine. 2017 Nov 1
• 5 citations
  Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis.
  Oluchi Oke, Tarsheen K. Sethi, Stacey Goodman, Sharon Phillips, Ilka Decker, Samuel M. Rubinstein, Beatrice P. Concepcion, Sarah N. Horst, Madan Jagasia, Adetola A. Ka...> ;Biology of Blood and Marrow Transplantation. 2017 Sep 1
• 11 citations
  Novel pathologic scoring tools predict end-stage kidney disease in light chain (AL) amyloidosis.
  Samuel M. Rubinstein, Liping Du, Beatrice P. Concepcion, Stacey Goodman, Shelton L. Harrell, Sara N. Horst, Daniel J. Lenihan, David Slosky, Agnes B. Fogo, Anthony Lan...> ;Amyloid. 2017 Jul 31
• 310 citations
  Cell-Free DNA and Active Rejection in Kidney Allografts
  Roy D. Bloom, Jonathan S. Bromberg, Emilio D. Poggio, Suphamai Bunnapradist, Anthony Langone, Puneet Sood, Arthur J. Matas, Shikha Mehta, Roslyn B. Mannon, Asif Sharfu...> ;Journal of the American Society of Nephrology. 2017 Jul 1
• 20 citations
  Has the Department of Veterans Affairs Found a Way to Avoid Racial Disparities in the Evaluation Process for Kidney Transplantation
  Michael A. Freeman, John R. Pleis, Kellee R. Bornemann, Emilee Croswell, Mary Amanda Dew, Chung-Chou H. Chang, Galen E. Switzer, Anthony Langone, Anuja Mittal-Henkle, ...> ;Transplantation. 2017 Jun 1
• 3 citations
  Acute Rejection of a Kidney Transplant in a Patient With Common Variable Immunodeficiency: A Case Report.
  O. Al Nimri, A. Rajput, E. Martinez, John M. Fahrenholz, Paisit Paueksakon, A. Langone, B.P. Concepcion> ;Transplantation Proceedings. 2017 Mar 1
• 2 citations
  IgA-Dominant Acute Postinfectious Glomerulonephritis Presenting as Acute Renal Failure in a Kidney Transplant Recipient
  Manish Anand, Juan Pablo Arroyo, Hassan Alhalabi, Timothy E. Thayer, Mark A Lusco, Anthony Langone, Beatrice P. Concepcion> ;Kidney International Reports. 2017 Jan 31
• 6 citations
  Non-immunoglobulin A mesangial immune complex glomerulonephritis in kidney transplants.
  Giovanna A. Giannico, Shanna A. Arnold, Anthony Langone, Heidi M. Schaefer, J. Harold Helderman, David Shaffer, Agnes B. Fogo> ;Human Pathology. 2015 Oct 1
• 74 citations
  Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study.
  Anthony Langone, Steven Steinberg, Roberto Gedaly, Laurence Chan, Tariq Shah, Kapil D. Sethi, Vincenza Nigro, John C. Morgan> ;Clinical Transplantation. 2015 Sep 1
• Might the Current Gauge of Transplant Center Quality Result in Reducing Patient Access via Diminished Organ Utilization
  Swee Ling Levea, Anthony Langone> ;Clinical Journal of the American Society of Nephrology. 2014 Oct 7
• 6 citations
  Long‐term dosing patterns of enteric‐coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation
  Anthony Langone, Fuad S. Shihab, Oleh Pankewycz, Cataldo Doria, Anne Wiland, Kevin McCague, Laurence Chan> ;Clinical Transplantation. 2014 Sep 1
• 25 citations
  A longitudinal assessment of adherence with immunosuppressive therapy following kidney transplantation from the Mycophenolic Acid Observational REnal Transplant (MORE)...
  Demetra Tsapepas, Anthony Langone, Laurence Chan, Anne Wiland, Kevin McCague, Marie A. Chisholm-Burns> ;Annals of Transplantation. 2014 Apr 17
• Persistent shortness of breath in a kidney transplant recipient.
  Faris A. Ahmed, J. H. Helderman, Anthony Langone, Heidi M. Schaefer> ;American Journal of Transplantation. 2014 Apr 1
• 17 citations
  Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Trans...
  Anthony Langone, Cataldo Doria, Stuart M. Greenstein, Mohanram Narayanan, Kimi Ueda, Bashir Sankari, Oleh Pankewycz, Fuad S. Shihab, Laurence Chan> ;Clinical Transplantation. 2013 Jan 1
• 3 citations
  Mammalian Target of Rapamycin Inhibitors in Organ Transplantation: An Unkept Promise
  Anthony Langone, J. Harold Helderman> ;Chest. 2012 Sep 1
• Join now to see all

Journal Articles

• Reduced BK Virus Nephropathy but Increased Acute Rejection with Mycophenolate Mofetil Dose Reduction in Kidney Transplantation.  
  Shaffer D, Langone A, Nylander W A, Kizilisik T, Helderman J H, Graft; 7(1); 31-32

Books/Book Chapters

• The Kidney Physiology and Pathophysiology. 
  Chapter: Homeostasis of Solute and Water by the Transplanted Kidney 
  Page 2737 - 2761Helderman JH, Schaefer H, Langone A, Goral SSeldin & GiebischEdition 4th,
• Nissenson & Fine: Dialysis Therapy. 
  Chapter: End-Stage Renal Failure in the Diabetic Patient 
  Page 1061 - 1075Giullian J, Langone AJEdition 4th,
• Medical Management of the Renal Transplant Recipient. 
  Chapter: Immunosuppression 
  Page 127 - 137Langone AJ, Helderman JHEditors: Weir M.Edition 1st,
• Current Therapy in Allergy Immunology & Rheumatology. 
  Chapter: Therapeutic Approach to Renal Transplantation 
  Page 130 - 134Langone AJ, Helderman JHLichtenstein, Busse & Geha, LichtensteinEdition 6th,
• Kidney Transplantation. 
  Chapter: Immunosuppressive Drug Therapy 
  Page 39 - 54LangoneAJ, Helderman JHHricik
• Comprehensive Clinical Nephrology. 
  Chapter: Prophylaxis and Treatment of Renal Transplant Rejection 
  Page 1093 - 1103Ramanathan V, Langone AJJohnson & FeehallyEdition 2nd,
• Dialysis Therapy. 
  Chapter: Hemodialysis for End Stage Diabetic Nephropathy 
  Page 425 - 429Langone AJ, Lewis JNissenson & FineEdition 3rd,
• Principles and Practice of Renal Transplantation. 
  Page 1439 - 1440Langone AJ, Helderman JHKahan& Ponticelli’s
• Join now to see all

Abstracts/Posters

• The Prevalence of Patients Referred for Renal Transplantation that have Achieved Age Appropriate Standard of Care Cancer Screening Including Colonoscopy, Mammography, ...
  A. Langone, S. Walters, H. Schaefer, D. Hale, D. Shaffer, S. Bala, B. Concepcion, JH Helderman, ATC
• Early Outcome Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Registry: Initial Comparisons of Enteric-Coated Mycophenolate Sodium and Mycophen...
  A. Langone, L. Chan, S. Greenstein, R. Carson, A. Wiland, K McCague, C Doria, ATC
• Early Adherence with Immunosuppressant Medications: One-Year Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Registry.
  M. Chisholm-Burns, L. Chan, A. Langone, J. Wang, P. Lake, W. Irish, ATC
• Mycophenoic Acid (MPA) Therapy in Kidney Transplantation: An Analysis of the MORE Registry.
  Irish W, Doria C, Greenstein S, Chan L, Narayanan M, Ueda K, Sankari B, Langone A, ASN
• Mycophenolic Acid (MPA) Therapy in Diabetic Kidney Transplant Patients: An Analysis of the MORE Registry.
  Irish W, Doria C, Greenstein S, Chan L, Narayanan M, Ueda K, Sankari B, Langone A, ASN
• Conversion from Mycophenolate Mofetil (MMF) to Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Recipients with Diabetes Mellitus.
  Langone A, Chan L, Wiland A, McCague K, Bolin P, Cooper M, ASN
• The Mycophenolic Acid Observational Renal Transplant Study (MORE) Registry: Summary of Patient Management in De Novo Renal Transplantation.
  Irish W, Greenstein S, Doria C, Chan L, Narayanan M, Ueda K, Langone A, WTC
• Steroid Avoidance in African American Patients Undergoing Kidney Transplantation.
  Schaefer H, Sakai L, Feurer I, Buchanon C, Langone A, Helderman J, Nylander W, Shaffer D, WTC
• The Utility of Immunofluorescence and Electron Microscopy in Renal Transplant Biopsies.
  Langone AJ, Nitschke A, Helderman JH, Schaefer H, Nylander W, Shaffer D, Kizilisik T, Chuang P, Moeckel G, Fogo A, WTC
• Conversion from Tacrolimus to Cyclosporine and Withdrawal of Mycophenolate Mofetil in Polyoma Nephropathy Patients.
  Chakravarty A, Schaefer H, Helderman JH, Shaffer D, Langone A, WTC
• The Rate and Risk Factors Associated with Bone Fractures in Renal Transplant Patients.
  Langone AJ, Gray J, Buchanan C, Schaefer H, Helderman JH, Shaffer D, Kizilisik T, Nylander W, Chuang P, WTC
• A Non Randomized, Retrospective Review of Simulect Versus Thymoglobulin As Induction Agents for Kidney Transplantation at a Single Transplant Center.
  Chuang P, Buchanan C, Kizilisik T, Schaefer H, Chakravarty A, Helderman JH, Nylander W, Shaffer D, Langone AJ, WTC
• Calcineurin Inhibitor Avoidance in Kidney Transplantation: A Prospective, Randomized, Single-Center Trial of Sirolimus Versus Tacrolimus with Thymoglobulin Induction.
  Shaffer D, Schaefer HM, Feurer I, Helderman JH, Langone AJ, Nylander WA, WTC
• Preliminary Results of Early Steroid Withdrawal in African American Patients Undergoing Kidney Transplantation.
  Schaefer HM, Feurer I, Helderman JH, Langone AJ, Kizilisik AT, Nylander WA, Shaffer D, WTC
• Calcineurin Inhibitor Avoidance VS Steroid Avoidance Following Kidney Transplantation: Post-Operative Complications.
  18. Shaffer D, Kizilisik AT, Helderman JH, Langone AJ, Nylander WA, Feurer I, Schaefer HM, WTC
• Short-Term Results Under Three Different Immunosuppressive Regimens at One Center.
  Schaefer HM, Kizilisik AT, Feurer I, Langone AJ, Helderman JH, Nylander WA, Shaffer D, WTC
• High Prevalence of Erectile Dysfunction After Kidney Pancreas Transplantation.
  Butler L, Shaffer D, Feurer I, Langone AJ, Helderman JH, Kizilisik AT, Nylander WA, Schaefer HM, WTC
• Inadequate Dobutamine Stress Echo Based on Target Heart Rate in Patients with ESRD Presenting for Transplantation: Is Cardiac Catherization Necessary?
  Schaefer H, Langone A, Helderman JH, Am Soc Nephrol 16
• C4d Staining and Donor Specific Antibodies in Renal Allografts: Diagnostic and Therapeutic Implications.
  Schaefer H, Langone A, Kizilisik T, Nylander W, Shaffer D, Moeckel G, Fogo A, Crowe D, Helderman JH, J Am Soc Nephrol 16
• Urinary Tract Infections Increase the Risk of Mortality After Renal Transplantation.
  Chuang P, Ray J, Edmondson B, Shaffer D, Kizilisik T, Nylander WN, Helderman JH, Langone A, Oral Presentation AST
• The Effect of CREG Matching on Graft Survival and HLA Sensitization in Renal Transplant Recipients.
  Crowe D, Langone A, Shaffer D, Kizilisik T, Nylander WN, Helderman JH, Oral Presentation AST
• Reduced Risk of BK Virus but Increased Risk of Rejection with Mycophenolate Mofetil Dose Reduction Following Kidney Transplantation.
  Shaffer D, Nylander WN, Kizilisik T, Helderman JH, Langone A, Poster Presentation AST
• Living Kidney Donation: Prevalence and Etiology of Potential Donor Unsuitability.
  Langone, AJ, Fischbach, B, Ray, J et al, Poster Presentation ASN
• The Preceding Symptomatology, Histology and Prevalence Rate of Renal Transplant Nephrectomies.
  Langone AJ, Karipidis M, Meyer J, et al, Poster ASN
• Renal Transplantation Improves Biomarkers of Oxidative Stress in Patients with End-Stage Renal Disease (ESRD).
  Simmons E, Langone A, Recupero P, et al, Poster ASN
• Join now to see all

Lectures

• Management of the Failing and Failed Renal Transplant. 
  National Kidney Foundation, Las Vegas
• Are We Failing to Adequately Care for Patients with Failing Kidney Transplants? 
  American Society of Nephrology, Denver
• Early Adherence with Immunosuppressant Medications: One-Year Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. 
  American Transplant Congress, San Diego
• Improving Renal Transplant Outcomes: Sharing Best Practice from the US. 
  Multiple locations, 2006, 2008
• Hypertension, Diabetes and Nephropathy. & Improving Renal Transplant Outcomes: Sharing Best Practice from the US. 
  Advances in Medicine Conference. University of the West Indies. Jamaica, WVI
• Approach to the Sensitized Patient. 
  Nurse Practitioners Transplant Symposium, Nashville, Tennessee
• Hypertension in renal transplantation. 
  Nurse Practitioners Transplant Symposium, Nashville, Tennessee
• Preparing Your Patient for Renal Transplantation. 
  National Kidney Foundation of Tennessee Conference, Memphis, Tennessee
• Optimizing Renal Transplant Outcomes: How Can We Prolong the Magic? 
  Multiple locations, 2006
• Management of Post-Transplantation Bone Disease. 
  Multiple locations, 2004
• Chronic Allograft Nephropathy: Redefining the pathology. 
  Multiple locations, 2004
• Current Issues in IL-2 Receptor Monoclonal Antibody Therapy. 
  Multiple locations, 2004
• Hypertension, Diabetes and Resultant Nephropathy: The Role of Angiotensin Receptor Blockers. 
  5th Annual Primary Care Forum. Blount County Medical Society. Oneonta, Alabama
• Post Transplantation Diabetes. 
  St. Luke’s Hospital, Milwaukee Wisconsin
• Join now to see all